The horse is out of the barn. I don't know how Offit/Orac/Snyderman et. al. are gonna get it back in.
Autism is environmental. You heard it in congress. Barbara Boxer even learned the word "epigenetics".
News and commentary on the autism epidemic and my beautiful boy who is living with autism.
Senators to review research on autism's enviro causes
Environment and Energy Daily
August 2, 2010
Gayathri Vaidyanathan, E&E reporter
The Senate Environment and Public Works Committee will meet tomorrow to probe the state of research into the environmental causes of autism and other neurodevelopment disorders.
The Children's Health Subcommittee will hear from U.S. EPA and National Institutes of Health officials on the progress of federally funded work into the causes of autism and other development disorders of the brain.
It is likely that the hearing will be a step toward reauthorizing the 2006 Combating Autism Act, which is set to expire in 2011.
Autism is thought to result from a combination of genetic and environmental factors. While the interaction of genes and mutations is somewhat known by now, little work has been done on potential environmental risk factors. There are likely to be many disparate causes leading to autism.
The incidence of autism spectrum disorders, or ASDs, is increasing in the United States, with one in every 110 children affected. Rates of attention deficit hyperactivity disorder, or ADHD, in children are also rising -- nearly 4.5 million children between 3 and 17 years of age have it, according to the U.S. Centers for Disease Control and Prevention.
The subpanel will hear from Isaac Pessah, director of the University of California, Davis, Children's Center for Environmental Health and Disease Prevention, which has received $7.5 million from EPA since 2007 for research to investigate possible environmental causes.
UC Davis is working on a project called MARBLES (Markers of Autism Risk in Babies -- Learning Early Signs) to identify early predictors of autism, whether genetic, environmental or immunologic. According to the project proposal submitted to EPA, the project will look at whether autistic children are differently exposed to metals, pesticides, polybrominated diphenylethers and other chemicals.
The work is a corollary to a long-term study called CHARGE in which UC Davis researchers are casting a wide net to catch possible environmental contributors in a group of 2- to 5-year-old autistic children. They are screening for pesticides, metals, flame retardant compounds, viruses and bacteria and pharmaceuticals.
UC Davis and other groups are also receiving money from NIH's National Institute of Environmental and Health Sciences and National Toxicology Program, and the subcommittee will hear from the program's director, Linda Birnbaum.
NIH is funding a study together with the nonprofit Autism Speaks that is enrolling mothers who already have one autistic child and are again pregnant to study exposures during fetal development.
The annual cost of caring for people with autism is $35 billion, according to Geraldine Dawson, chief scientific officer at Autism Speaks.
NIH has provided nearly $225 million for research, which Dawsom called miniscule. The funding comes from the Combating Autism Act, which authorized $7 billion for autism-related work including screening, education, intervention and research.
"President Obama has listed autism as one of three health concerns to be combated in the United States," Dawson said. "The current act is a step in the right direction, but due to the magnitude of the public health challenge that autism presents, we need a great deal more funding."
The rate of children with the disease has risen by 600 percent in the last decade, a number so dramatic it cannot be explained solely by better diagnosis, Dawson said.
Schedule: The hearing is tomorrow at 10 a.m. in 406 Dirksen.
Witnesses: Paul Anastas, assistant administrator of the Office of Research and Development, U.S. EPA; Linda Birnbaum, NIH's director of the National Institute of Environmental and Health Sciences and National Toxicology Program; Isaac Pessah, director of the UC Davis Children's Center for Environmental Health and Disease Prevention; Bruce Lanphear, senior scientist at the Child & Family Research Institute; and Mary Moen, parent.
In a lovely ironic touch, the conference hall is only a few steps from the Ferris wheel in the Orson Welles film noir classic set in postwar Vienna, “The Third Man.” On it, a cynical dealer of counterfeit drugs tells his pursuer to look down at the people below and says: “Victims? Don’t be melodramatic.... Would you really feel any pity if one of those dots stopped moving forever?”

Service Will Incinerate Unused H1N1 Vaccine
Jul 23, 2010
Clean Harbors, based in Norwell, Mass., is offering the service to health care providers because multiple doses of the vaccine contain enough mercury-based Thimerosal to be treated as a hazardous waste.
Clean Harbors of Norwell, Mass., now offers H1N1 Vaccination Incineration Services that will profile, collect, and dispose of unused 2009 H1N1 vaccine for health care customers nationwide. Multiple doses of the vaccine contain enough mercury-based Thimerosal to be treated by EPA as a hazardous waste and will be incinerated. Vaccine dated at the end of 2008 and early 2009 is now at the end of its shelf life and must be disposed, according to the company.
The HHS declaration of a 2009 H1N1 Public Health Emergency expired on June 23.
"We have seen many customers in various states looking for our H1N1 disposal capabilities," John C. Kelsey, the company's vice president, Healthcare Services, said in a July 22 e-mailed reply to questions about the service. "We wanted to announce it to the larger community as we are growing our customer count related to Healthcare Services. We have done a good amount of work in this area with vaccines through our hospital Pharmaceutical Waste programs."
He said the cost varies but is "generally the same pricing as other materials requiring hazardous waste incineration. The vaccine doses are in inventory and will be shipped via DOT packages for proper disposal," Kelsey added. "We are seeing multiple truckloads per week of the vaccine now and cannot align total amounts but we do expect the need to occur from many locations as the normal pathway for outdated items."
OLFA North America
Unused vaccine doses normally are returned through Reverse Distributors, but these have no value and thus must be disposed as a waste, he said, continuing, "It is good that PHER funds can be used to reimburse organizations for the disposal process."
CDC mandates proper disposal of H1N1 vaccines and allows Public Health Emergency Response (PHER) funds to be available for the disposal. Health care providers interested in the service can call 888-304-7035, e-mail healthcareservices@cleanharbors.com, or visit www.cleanharbors.com/healthcare.
Treatment for Toxic Vaccine Exposure, from Russell Blaylock, M.D.
The Following was composed by Dr. Russell Blaylock as a method to reduce autoimmune reactions to the flu vaccines only. Do not use this if you have the flu itself. These are just general observations and not medical advice. You should work with your doctor for a specific program.Treatment for Toxic Vaccine Exposure
1. Place a cold compress on the site of the injection immediately after the injection and continue this as often as possible for at least two days. If symptoms of fever, irritability, fatigue or flu-like symptoms reoccur -- continue the cold compresses until they abate. A cold shower or bath will also help.
2. Take fish oils -- I recommend the Norwegian fish oil made by Carlson Labs -- it has the correct balance of EPA and DHA to reduce the cytokine storm. The dose is one tablespoon a day -- if severe symptoms develop -- two tablespoons a day until well and then switch to one tablespoon a day. Children -- one teaspoon a day.
3. Curcumin, quercetin, ferulic acid and ellagic acid as a mixture -- the first two must be mixed with extravirgin olive in one teaspoon. Take the mix three times a day (500 mg of each)
4. Vitamin E (natural form) 400 IU a day (high in gamma-E)
5. Vitamin C 1000 mg four times a day
6. Astaxanthin 4 mg a day
7. Zinc 20 mg a day for one week then 5 mg a day
8. Avoid all immune stimulating supplements (mushroom extracts, whey protein) except beta-glucan -- it has been shown to reduce inflammation, microglial activation and has a reduced risk of aggravating autoimmunity, while increasing antiviral cellular immunity.
9. Take a multivitamin/mineral daily (one without iron -- Extend Core)
10. Magnesium citrate/malate 500 mg of elemental magnesium two capsules three times a day
11. Vitamin D3:
All Children -- 5000 IU a day for two weeks after vaccine then 2000 IU a day thereafter
Adults -- 20,000 IU a day after vaccine for two weeks then 10,000 IU a day thereafter
Take 500 mg to 1000 mg of calcium citrate a day for adults and 250 mg a day for children under age 12 years.
12. Avoid all mercury-containing seafood
13. Avoid omega-6 oils (corn, safflower, sunflower, soybean, canola and peanut oils)
14. Blenderize parsley and celery and drink 8 ounces twice a day
15. Take Jatoba tea extract (add 20 drops in on cup of tea) one day before the vaccine and the twice a day thereafter. (you can get it at http://www.iherb.com/Amazon-Therapeutics-Jatoba-1-oz-30-ml/14429?at=0) It is inexpensive.

Influence of pediatric vaccines on amygdala growth and opioid
ligand binding in rhesus macaque infants: A pilot study
Acta Neurobiol Exp 2010, 70: 147–164
©2010 by Polish Neuroscience Society - PTBUN, Nencki Institute of Experimental Biology
Laura Hewitson1,2,*, Brian J. Lopresti3, Carol Stott4, N. Scott Mason3 and Jaime Tomko1
1Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA;
2Thoughtful House Center for Children, Austin, TX, USA; 3Department of Radiology, University of Pittsburgh School of
Medicine, Pittsburgh, PA, USA; 4Independent Chartered Scientist, Cambridge, UK;
*Email: lch1@pitt.edu
This longitudinal, case-control pilot study examined amygdala growth in rhesus macaque infants receiving the complete US childhood vaccine schedule (1994-1999). Longitudinal structural and functional neuroimaging was undertaken to examine central effects of the vaccine regimen on the developing brain. Vaccine-exposed and saline-injected control infants underwent MRI and PET imaging at approximately 4 and 6 months of age, representing two specific timeframes within the vaccination schedule. Volumetric analyses showed that exposed animals did not undergo the maturational changes over time in amygdala volume that was observed in unexposed animals. After controlling for left amygdala volume, the binding of the opioid antagonist [11C]diprenorphine (DPN) in exposed animals remained relatively constant over time, compared with unexposed animals, in which a significant decrease in [11C]DPN binding occurred. These results suggest that maturational changes in amygdala volume and the binding capacity of [11C]DPN in the amygdala was significantly altered in infant macaques receiving the vaccine schedule. The macaque infant is a relevant animal model in which to investigate specific environmental exposures and structural/functional neuroimaging during neurodevelopment.
Key Words: rhesus macaques, Macaca mulatta, non-human primates, animal model, neuroimaging, PET, MRI, amygdala, opioids, ethyl mercury, thimerosal, neurotoxicity
An alarming finding is reported by Hewitson and coworkers showing that, in infant monkeys that were immunized, the amygdala does not show the normal pattern of maturation but is hypertrophied. Although these are only preliminary data, given the well-known role of the amygdala in generation of fear and other negative emotions, they support the possibility that there is a link between early immunization and the etiology of autism.
"I’m concerned about immunization policy and how you protect immunization."
Warning, Gardasil may cause increased risk of cervical cancer
June 30, 10:34 Norma Erickson
Buyer beware: Gardasil, given under the wrong conditions, may increase the risk of cervical cancer.
Would you consent to giving your child a vaccine that caused an increased risk of cancer? That may be exactly what you are doing when you consent to Gardasil.
According to Information the manufacturer of this vaccine presented to the FDA prior to approval, if a person has already been exposed to HPV 16 or 18 prior to injection Gardasil increases the risk of precancerous lesions, or worse, by 44.6%. (See VRBPAC Background document, bottom of page 13) This documentation was presented on the 18th of May 2006.
That statement bears repeating, if you have been exposed to HPV 16 or 18 prior to injection and take the vaccine, you increase your risk of precancerous lesions, or worse, by 44.6%.
Is this information advertised? No! This information was actually presented to the FDA by Merck. It came from their own safety trials. The FDA did not respond by recommending screening for HPV prior to vaccination. The FDA did not even demand a warning be included in the package insert....
IVF Linked to Autism, Israeli Study Suggests
ScienceDaily (June 30, 2010) — The first "test tube baby" was born in 1978. With advances in reproductive science, an estimated one percent of all American babies are now born each year through in vitro fertilization (IVF). But IVF and other assisted fertility treatments may be solving one problem by creating another, suggests new evidence from Tel Aviv University.
In a recent study, Dr. Ditza Zachor of Tel Aviv University's Sackler School of Medicine reported a strong link between IVF and mild to moderate cases of autism. Her findings were presented last month at the International Meeting for Autism Research in Philadelphia.
According to her research at the Autism Center at the Assaf Harofeh Medical Center in Israel, which Dr. Zachor directs, 10.5% of 461 children diagnosed with a disorder on the autism spectrum were conceived using IVF, a significantly higher number than the 3.5% autism rate in the general Israeli population.